SUN PHARMA ADVANCED RESEARCH COMPANY Financial Statement Analysis
|
||
|
The Revenues of SUN PHARMA ADVANCED RESEARCH COMPANY have decreased by -68.36% YoY .
The Earnings Per Share (EPS) of SUN PHARMA ADVANCED RESEARCH COMPANY has decreased by Negative YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Annual Financial Results
[BOM: 532872|NSE : SPARC]
| Standalone | Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 |
|---|---|---|---|---|---|
| Operating Income | ₹76 Cr | ₹239 Cr | ₹137 Cr | ₹253 Cr | ₹77 Cr |
| Operating Expenses | ₹140 Cr | ₹180 Cr | ₹134 Cr | ₹210 Cr | ₹30 Cr |
| Expenses | ₹479 Cr | ₹453 Cr | ₹324 Cr | ₹388 Cr | ₹387 Cr |
| Operating Profit (Excl OI) | ₹-404 Cr | ₹-214 Cr | ₹-187 Cr | ₹-135 Cr | ₹-310 Cr |
| Other Income | ₹29 Cr | ₹11 Cr | ₹6.85 Cr | ₹5.41 Cr | ₹9.76 Cr |
| Interest | ₹1.66 Cr | ₹7.64 Cr | ₹13 Cr | ₹11 Cr | ₹2.68 Cr |
| Depreciation | ₹12 Cr | ₹12 Cr | ₹10 Cr | ₹11 Cr | ₹9.48 Cr |
| Profit Before Tax | ₹-388 Cr | ₹-223 Cr | ₹-203 Cr | ₹-151 Cr | ₹-312 Cr |
| Profit After Tax | ₹-388 Cr | ₹-223 Cr | ₹-203 Cr | ₹-151 Cr | ₹-312 Cr |
| Earnings Per Share (Rs) | ₹-11.96 | ₹-6.86 | ₹-7.48 | ₹-5.77 | ₹-11.92 |
| PAT Margin (%) | -513.74 | -93.22 | -148.19 | -59.75 | -406.70 |
| ROE(%) | -121.73 | -143.72 | 0.00 | 0.00 | -225.08 |
| ROCE(%) | -112.88 | -69.44 | -225.57 | -254.10 | -178.95 |
| Total Debt/Equity(x) | 0.38 | 0.00 | -0.37 | -1.37 | -3.59 |
Key Financials |
||
| Market Cap | : | ₹ 6,178.5 Cr |
| Revenue (TTM) | : | ₹ 60.1 Cr |
| Net Profit(TTM) | : | ₹ -410.9 Cr |
| EPS (TTM) | : | ₹ -12.7 |
| P/E (TTM) | : | - |
| Industry Peers & Returns | 1W | 1M | 1Y |
| SUN PHARMA ADVANCED RESEARCH COMPANY | -4.1% | -9.1% | -22.3% |
| SYNGENE INTERNATIONAL | -1.4% | -0.9% | 18.4% |
| LATENT VIEW ANALYTICS | -6.3% | -8.8% | 8.3% |
| JUST DIAL | -1% | -9.7% | 53.3% |
| DREAMFOLKS SERVICES | 0.8% | -8.3% | -22.5% |
| EKI ENERGY SERVICES | -7.2% | -27.6% | -47.8% |
| AGS TRANSACT TECHNOLOGIES | -2.9% | -12% | 3.3% |
| JAYKAY ENTERPRISES | 6.7% | -11.5% | 166.6% |
| QUINT DIGITAL | -3.2% | -6.5% | -53% |
SUN PHARMA ADVANCED RESEARCH COMPANY Revenues
[BOM: 532872|NSE : SPARC]
| Y-o-Y | -68.36 % |
| 5 Yr CAGR | -0.42 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2024 | ₹76 Cr | -68.36 | |
| Mar2023 | ₹239 Cr | 73.98 | |
| Mar2022 | ₹137 Cr | -45.74 | |
| Mar2021 | ₹253 Cr | 229.31 | |
| Mar2020 | ₹77 Cr | - | |
SUN PHARMA ADVANCED RESEARCH COMPANY Operating Profit
[BOM: 532872|NSE : SPARC]
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2024 | ₹-404 Cr | Negative | |
| Mar2023 | ₹-214 Cr | Negative | |
| Mar2022 | ₹-187 Cr | Negative | |
| Mar2021 | ₹-135 Cr | Negative | |
| Mar2020 | ₹-310 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2024 | -534.51% | Negative | |
| Mar2023 | -89.65% | Negative | |
| Mar2022 | -136.07% | Negative | |
| Mar2021 | -53.36% | Negative | |
| Mar2020 | -403.59% | - | |
SUN PHARMA ADVANCED RESEARCH COMPANY Profit After Tax
[BOM: 532872|NSE : SPARC]
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2024 | ₹-388 Cr | Negative | |
| Mar2023 | ₹-223 Cr | Negative | |
| Mar2022 | ₹-203 Cr | Negative | |
| Mar2021 | ₹-151 Cr | Negative | |
| Mar2020 | ₹-312 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2024 | -513.74 % | Negative | |
| Mar2023 | -93.22 % | Negative | |
| Mar2022 | -148.19 % | Negative | |
| Mar2021 | -59.75 % | Negative | |
| Mar2020 | -406.7 % | - | |
SUN PHARMA ADVANCED RESEARCH COMPANY Earnings Per Share (EPS)
[BOM: 532872|NSE : SPARC]
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2024 | ₹-12 | Negative | |
| Mar2023 | ₹-6.86 | Negative | |
| Mar2022 | ₹-7.48 | Negative | |
| Mar2021 | ₹-5.77 | Negative | |
| Mar2020 | ₹-12 | - | |
SUN PHARMA ADVANCED RESEARCH COMPANY Return on Capital Employed (ROCE)
[BOM: 532872|NSE : SPARC]
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2024 | -112.88% | Negative | |
| Mar2023 | -69.44% | Negative | |
| Mar2022 | -225.57% | Negative | |
| Mar2021 | -254.1% | Negative | |
| Mar2020 | -178.95% | - | |
SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex
| Current Share Price | : | ₹190.4 |
| Current MarketCap | : | ₹ 6,178.5 Cr |
| Updated EOD on | : | Nov 21,2024 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMA ADVANCED RESEARCH COMPANY | -4.1% |
-9.1% |
-22.3% |
| SENSEX | -1.9% |
-5% |
17.5% |
SUN PHARMA ADVANCED RESEARCH COMPANY related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| S&P BSE ALLCAP | -0.3% | -3.5% | 35.8% |
| S&P BSE HEALTHCARE | -1.8% | -4.1% | 46.6% |
| S&P BSE 400 MIDSMALLCAP | -2.2% | -7.9% | 31.4% |
| S&P BSE MIDSMALLCAP | -2.3% | -7.5% | 33.6% |
| S&P BSE 500 | -2.3% | -7% | 24.1% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY MID SMALL400 | -2.1% | -7.6% | 30.6% |
| NIFTY 500 | -2.3% | -6.9% | 24.6% |
| NIFTY500 MULTICAP 50:25:25 | -2.3% | -7.2% | 26.5% |
| NIFTY SMALLCAP250 | -2.6% | -8.2% | 30.1% |
You may also like the below Video Courses
FAQ about SUN PHARMA ADVANCED RESEARCH COMPANY Financials
How the annual revenues of SUN PHARMA ADVANCED RESEARCH COMPANY have changed ?
The Revenues of SUN PHARMA ADVANCED RESEARCH COMPANY have decreased by -68.36% YoY .
How the Earnings per Share (EPS) of SUN PHARMA ADVANCED RESEARCH COMPANY have changed?
The Earnings Per Share (EPS) of SUN PHARMA ADVANCED RESEARCH COMPANY has decreased by Negative YoY .
Check out Intrinsic Value of Peers of SUN PHARMA ADVANCED RESEARCH COMPANY
Compare Stock Analytics of Peers of SUN PHARMA ADVANCED RESEARCH COMPANY
SYNGENE INTERNATIONAL LTD vs SUN PHARMA ADVANCED RESEARCH COMPANY LTD vs LATENT VIEW ANALYTICS LTD
JUST DIAL LTD vs DREAMFOLKS SERVICES LTD vs
SYNGENE INTERNATIONAL LTD vs SUN PHARMA ADVANCED RESEARCH COMPANY LTD vs LATENT VIEW ANALYTICS LTD
JUST DIAL LTD vs DREAMFOLKS SERVICES LTD vs
